登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
PDAC IC50 when treated with gefitinib or cetuximab.
PDAC IC50 when treated with gefitinib or cetuximab.
收藏
Figshare
2019-03-28 更新
2026-04-29 收录
胰腺癌药物敏感性
靶向治疗疗效评估
数据链接：
https://figshare.com/articles/dataset/PDAC_IC50_when_treated_with_gefitinib_or_cetuximab_/7912481
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
PDAC IC50 when treated with gefitinib or cetuximab.
应用场景：
创建时间：
2019-03-28
相关数据集
Additional file 3: of iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes
癌症驱动基因
靶向治疗疗效评估
Table of targeted therapy TCGA samples with progressive disease. (XLSX 9Â kb)
Figshare
2016-12-23 更新
7
0
Supplementary Table 1 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
胰腺癌药物敏感性
合成致死机制
IC50 and PTGR1 expression
NIAID Data Ecosystem
5
0
Treatment time on EGFR TKIs.
靶向治疗疗效评估
EGFR突变肺癌
Treatment time on EGFR TKIs.
Figshare
2018-11-27 更新
1
0
Additional file 13 of Comprehensive molecular analysis of 26 newly established human pancreatic ductal adenocarcinoma cell lines reveals two clusters with variating drug sensitivities
胰腺癌药物敏感性
特征分析
Additional file 13. Table S5. AUC values for Gemcitabine and 5-FU in cell lines stratified by patient clinical regimens and responses
NIAID Data Ecosystem
5
0
Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact
癌症预后生物标志物
靶向治疗疗效评估
Background: The prognostication of metastatic renal cell carcinoma (mRCC) is based on Memorial Sloan Kettering Cancer Center (MSKCC) and International Metastatic Renal Cell Carcinoma Database Consorti
Figshare
2018-11-27 更新
2
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
